Rheumatology
From the Journals
Women’s Risk for Lupus Rises With Greater Intake of Ultraprocessed Foods
The risk for SLE doubled in women with anti–double-stranded DNA antibodies.
From the Journals
Gout Drugs in Late-Phase Trials Might Increase Patients at Target Urate Level
New options in late stages of clinical testing for refractory gout promise to increase the chances of reaching the guideline uric acid target with...
News from the FDA/CDC
Pyzchiva Receives FDA Approval as Third Ustekinumab Biosimilar
The biosimilar is approved for all indications of the reference medication, Stelara, and will launch in February 2025.
From the Journals
Baricitinib Outperforms TNF Inhibitors in Real-World RA Trial
In a real-world trial, baricitinib was favored over TNF inhibitors in clinical and patient-reported outcomes after 12 weeks, but one expert...
Guidelines
‘Therapeutic Continuums’ Guide Systemic Sclerosis Treatment in Updated EULAR Recommendations
The recommendations highlighted the use of immunosuppressive agents and antifibrotics to treat skin fibrosis and lung fibrosis, as well as changes...
Latest News
Nurse-Led Care for Gout Generates Best Uric Acid Control
In gout management the treatment target is clear and nurses are often able to devote more time to a specific goal.
From the Journals
Sex-Related Differences Found in IgG4-Related Disease Epidemiology
A recent study highlighted sex-based differences in manifestations of IgG4-related disease.
Conference Coverage
Why Do Investigational OA Drugs Need Better Trial Endpoints? Lorecivivint Serves as an Example
The reason that disease-modifying osteoarthritis drugs remain elusive might be due to trial designs and targets not optimized for showing disease-...
Latest News
VEXAS Syndrome: Study Highlights Cutaneous Symptoms
Affected individuals exhibit a wide range of manifestations, including cytopenia/myelodysplasia, multiorgan systemic inflammation, and cutaneous...
Conference Coverage
Long-Term OA, RA Symptom Improvement Seen with Plant-Based Diet, Lifestyle Changes
The intervention for patients with OA and RA led to improved pain and stiffness, as well as improved disease activity. Mechanisms were thought to...
Conference Coverage
Trial Confirms Treating Gout Based on Uric Acid Level, Not Symptoms
Basing the treatment of gout on reaching and maintaining target serum uric acid level is already endorsed in guidelines, but a randomized trial...